[
  {
    "ts": "2026-01-20T00:12:50+00:00",
    "headline": "Pfizer (PFE) Valuation Check As Investors Reassess Recent Shareholder Returns",
    "summary": "Why Pfizer (PFE) Is Back on Investors’ Radar Pfizer (PFE) is attracting fresh attention after a period of mixed share performance, with the stock showing positive total returns over the past year despite weaker recent annual revenue and net income growth. See our latest analysis for Pfizer. Recent trading has been relatively steady, with a 90 day share price return of 3.22% and a 1 year total shareholder return of 4.59%, contrasting with a weaker 3 year total shareholder return of 32.17%...",
    "url": "https://finance.yahoo.com/news/pfizer-pfe-valuation-check-investors-001250364.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "5547d1a8-a5f7-3fa7-bd0a-6077cb9eaad2",
      "content": {
        "id": "5547d1a8-a5f7-3fa7-bd0a-6077cb9eaad2",
        "contentType": "STORY",
        "title": "Pfizer (PFE) Valuation Check As Investors Reassess Recent Shareholder Returns",
        "description": "",
        "summary": "Why Pfizer (PFE) Is Back on Investors’ Radar Pfizer (PFE) is attracting fresh attention after a period of mixed share performance, with the stock showing positive total returns over the past year despite weaker recent annual revenue and net income growth. See our latest analysis for Pfizer. Recent trading has been relatively steady, with a 90 day share price return of 3.22% and a 1 year total shareholder return of 4.59%, contrasting with a weaker 3 year total shareholder return of 32.17%...",
        "pubDate": "2026-01-20T00:12:50Z",
        "displayTime": "2026-01-20T00:12:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-valuation-check-investors-001250364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-valuation-check-investors-001250364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]